BioMarin Pharmaceutical Inc. buy Stifel Nicolaus
Start price
21.12.23
/
50%
€86.10
Target price
21.12.24
€91.85
Performance (%)
-19.14%
Price
24.05.24
€69.62
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -19.14%. This prediction currently runs until 21.12.24. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | -2.384% | -2.384% |
iShares Core DAX® | -0.205% | 2.528% |
iShares Nasdaq 100 | 1.613% | 4.733% |
iShares Nikkei 225® | -0.740% | 0.396% |
iShares S&P 500 | 0.267% | 2.720% |
Comments by Stifel_Nicolaus for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $101.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€98.41
01.08.24
01.08.24
-12.67%
24.05.24
24.05.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€94.17
28.02.23
28.02.23
€111.20
28.02.24
28.02.24
-13.41%
29.02.24
29.02.24